Total planned funding: $638,019,798
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $157,240,526 |
Uganda | $126,827,859 |
Mozambique | $82,679,126 |
Zambia | $71,762,946 |
Côte d'Ivoire | $53,888,477 |
Zimbabwe | $40,036,591 |
Tanzania | $30,619,745 |
Vietnam | $21,575,620 |
Rwanda | $17,458,028 |
South Africa | $10,410,828 |
Haiti | $10,266,982 |
Kenya | $5,976,445 |
Botswana | $4,682,446 |
Democratic Republic of the Congo | $1,502,692 |
Burundi | $1,258,202 |
Guyana | $1,099,493 |
Eswatini | $558,655 |
Cambodia | $51,538 |
Dominican Republic | $48,986 |
Angola | $34,000 |
Ukraine | $25,824 |
Ethiopia | $14,789 |
Organizational Types
Private Contractor | $528,310,230 |
NGO | $89,975,914 |
Host Country Government Agency | $9,166,554 |
Unknown | $7,981,518 |
Own Agency | $1,697,756 |
Other USG Agency | $569,897 |
FBO | $170,875 |
University | $147,054 |
Implementing Agency | $0 |
Program Areas
Treatment | $638,019,798 |
Budget Codes
HTXD: Treatment: ARV Drugs | $638,019,798 |
Top Partner Programs
Medical Access Uganda Limited:
$83,150,182
View countries